Our Clients' Success is Our Success
Distribution Strategy Mapped for Complex Oncolytic
How a pharmaceutical company determined the best distribution strategy for a challenging oncology product.
Distribution Fee Range Assessment Guides Negotiations
How a large manufacturer was able to leverage benchmark fee ranges to better negotiate distribution agreements.
Understanding COVID-19 Impacts to Logistics
How a cell therapy manufacturer was able to avoid COVID-19 disruptions to their distribution model.
Market Analysis Informs Biotech Distribution Strategy
How a biotech company was able to quickly understand the retinal landscape to build a commercial distribution strategy for their first launch.
Manufacturer Buys Stagnant Brands for Relaunch
How a new manufacturer successfully relaunched a stagnant product line with limited trade and distribution staff and experience.
How a small pharmaceutical manufacturer realized significant savings following a review of distribution partner contracts.
How a young biotech company with only a handful of employees was fully contracted and on schedule to implement in advance of launch.
How a growing manufacturer identified $2.7M in savings with a thorough analysis of their existing Distribution Service Agreements.
Cell Therapy Commercial
How a U.S. biotech company established a global supply chain for a cell therapy with complicated and unique characteristics.
33% Revenue Growth with Named Patient Program
How the Head of Global Market Access for an oral oncolytic was able to increase revenue potential by thinking outside the U.S.
SP Network for Oral Oncolytic with OTC Companion Needs
How a new oncology therapy used a well-designed SP network to overcome AE concerns and exceed sales expectations.
Updates to PAP Program Ensure Access for 40K Patients
How a large manufacturer methodically assessed and optimized a free goods program to avoid access disruptions.
Commercial Operations Assessment Drives
Efficiencies and Scalability
How a mid-sized manufacturer's commercial operations team increased efficiency, improved collaboration, and drove future scalability with a comprehensive third-party assessment.
How a manufacturer successfully prepared for a hybrid HUB launch by temporarily extending their team's expertise.
Assessment of Hybrid HUB Enables Optimization
How a thorough assessment of a manufacturer's patient services department helped optimize a Hybrid HUB for future success.
Resource Support for Mfr's Patient Services Team
How one manufacturer implemented several patient support initiatives over a 6-month period by bringing on temporary skilled staffing support.
HUB Overhaul Saves 25%;
Sales Increase 34%
How a pharmaceutical company revamped an old, inefficient HUB model to save 1/4 of their annual budget and increase sales by 1/3.
Transitioning HUB from Insourced to Outsourced
How a large manufacturer successfully transitioned an internal, 5-product HUB to a third-party vendor on schedule.
How a large, global manufacturer successfully managed a patient support launch strategy in a crowded specialty market on time and under budget.
Patient And Provider
How a small biotech successfully managed escalations around launch without adding staff.
How one manufacturer decreased time to fill by 2 months and boosted incremental revenue by $15M.
How implementing a Quality Management System helped a Brand team improve benefit verification accuracy by 4.8% in 2 months.
How a large manufacturer accelerated time to therapy with a full suite of digitalized services.
Patient Support Program Optimized with Market
How an established patient support program was able to identify and overcome design barriers to stimulate access.
Market Research Identifies Barriers to Cell Therapy Commercialization
How a manufacturer was able to identify and correct significant site of care issues ahead of launch.
Patient Support Services Model Pressure Tested and Validated
How a large manufacturer was able to identify additional access drivers for a PSP model design ahead of launch, while securing essential internal stakeholder support.
Market Research Guides Gene Therapy Commercial Strategy
How a biotech company was able to identify and address potential future commercial operational complexities early in clinical development
How one manufacturer is now leveraging more accurate, meaningful, and actionable data to make strategic decisions.
How an US-based cell therapy company overcame a tight timeline to gain insights from key stakeholders across 5 European markets.